Myoclonic dystonia
|
1.000 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Myoclonic dystonia
|
1.000 |
GermlineCausalMutation
|
disease |
ORPHANET |
|
|
|
Myoclonic dystonia
|
1.000 |
Biomarker
|
disease |
CTD_human |
|
|
|
Myoclonic dystonia
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
A major locus for myoclonus-dystonia maps to chromosome 7q in eight families.
|
11022010 |
2000 |
Myoclonic dystonia
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Myoclonus-dystonia syndrome (MDS; DYT11) is an autosomal dominant disorder characterized by bilateral, alcohol-sensitive myoclonic jerks involving mainly the arms and axial muscles.
|
11528394 |
2001 |
Myoclonic dystonia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Myoclonus-dystonia syndrome (MDS; DYT11) is an autosomal dominant disorder characterized by bilateral, alcohol-sensitive myoclonic jerks involving mainly the arms and axial muscles.
|
11528394 |
2001 |
Myoclonic dystonia
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Myoclonus-dystonia syndrome (MDS; DYT11) is an autosomal dominant disorder characterized by bilateral, alcohol-sensitive myoclonic jerks involving mainly the arms and axial muscles.
|
11528394 |
2001 |
Myoclonic dystonia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Myoclonus-dystonia is a movement disorder associated with mutations in the epsilon-sarcoglycan gene (SGCE) in most families and in the DRD2 and DYT1 genes in two single families.
|
12402271 |
2002 |
Myoclonic dystonia
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
SGCE deficiency seems to be the common pathogenetic mechanism in myoclonus-dystonia syndrome.
|
12325078 |
2002 |
Myoclonic dystonia
|
1.000 |
AlteredExpression
|
disease |
BEFREE |
Loss of imprinting in the patient with M-D who had biallelic expression of the SGCE gene was associated with partial loss of methylation at several CpG dinucleotides.
|
12444570 |
2002 |
Myoclonic dystonia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Myoclonus-dystonia has recently been associated with mutations in the epsilon-sarcoglycan gene (SCGE) on 7q21.
|
12391355 |
2002 |
Myoclonic dystonia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Autosomal dominant alcohol-responsive M-D is associated with mutations in the epsilon-sarcoglycan gene (SGCE) (six families) and with a missense change in the D2 dopamine receptor (DRD2)gene (one family).
|
12391346 |
2002 |
Myoclonic dystonia
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
SGCE deficiency seems to be the common pathogenetic mechanism in myoclonus-dystonia syndrome.
|
12325078 |
2002 |
Myoclonic dystonia
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Myoclonus-dystonia is a movement disorder associated with mutations in the epsilon-sarcoglycan gene (SGCE) in most families and in the DRD2 and DYT1 genes in two single families.
|
12402271 |
2002 |
Myoclonic dystonia
|
1.000 |
Biomarker
|
disease |
BEFREE |
SGCE deficiency seems to be the common pathogenetic mechanism in myoclonus-dystonia syndrome.
|
12325078 |
2002 |
Myoclonic dystonia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Severe myoclonus-dystonia syndrome associated with a novel epsilon-sarcoglycan gene truncating mutation.
|
12707948 |
2003 |
Myoclonic dystonia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
A novel mutation in the epsilon-sarcoglycan gene causing myoclonus-dystonia syndrome.
|
12743249 |
2003 |
Myoclonic dystonia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Myoclonus-dystonia syndrome (MDS) is a disorder for which the major cause appears to be mutations in the epsilon-sarcoglycan gene (SGCE).
|
12874409 |
2003 |
Myoclonic dystonia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The epsilon-sarcoglycan gene (SGCE), mutated in myoclonus-dystonia syndrome, is maternally imprinted.
|
12634861 |
2003 |
Myoclonic dystonia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Epsilon-sarcoglycan mutation accounts for a sub-group of myoclonus-dystonia, but other genes are still unidentified.
|
14628853 |
2003 |
Myoclonic dystonia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
We report on the second M-D family in which several clinically affected epsilon-sarcoglycan gene (SGCE) mutation carriers have seizures in addition to myoclonus and dystonia, adding to the evidence that epilepsy and EEG abnormalities may form part of the phenotypic spectrum of the condition.
|
15389977 |
2004 |
Myoclonic dystonia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Recently, mutations in the epsilon-sarcoglycan gene (SGCE) were shown to cause M-D.
|
15258227 |
2004 |
Myoclonic dystonia
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Recently, mutations in the epsilon-sarcoglycan gene (SGCE) were shown to cause M-D.
|
15258227 |
2004 |
Myoclonic dystonia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the epsilon-sarcoglycan gene (SGCE) have been reported in families with myoclonus-dystonia (M-D).
|
15368614 |
2004 |
Myoclonic dystonia
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Myoclonus-dystonia: detection of novel, recurrent, and de novo SGCE mutations.
|
15079037 |
2004 |